NUDT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.301800E-01
Normal-vs-Stage2
4.993400E-01
Normal-vs-Stage3
8.039000E-01
Normal-vs-Stage4
5.145000E-01
Stage1-vs-Stage2
8.838800E-01
Stage1-vs-Stage3
8.795600E-01
Stage1-vs-Stage4
8.085000E-01
Stage2-vs-Stage3
7.403800E-01
Stage2-vs-Stage4
8.535800E-01
Stage3-vs-Stage4
7.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.293000E-01
Normal-vs-AfricanAmerican
5.211200E-01
Normal-vs-Asian
6.902400E-01
Caucasian-vs-AfricanAmerican
7.621600E-01
Caucasian-vs-Asian
8.120200E-01
AfricanAmerican-vs-Asian
9.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.841000E-01
Normal-vs-Female
6.275600E-01
Male-vs-Female
3.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.998800E-01
Normal-vs-Age(41-60Yrs)
3.872600E-01
Normal-vs-Age(61-80Yrs)
6.577800E-01
Normal-vs-Age(81-100Yrs)
1.719370E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.845000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.853800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.548200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.095600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.930000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.963200E-01
Normal-vs-Daily Drinker
6.239400E-01
Normal-vs-Weekly Drinker
3.885200E-01
Normal-vs-Occasional Drinker
4.755600E-01
Normal-vs-Social Drinker
7.951800E-01
Non Drinker-vs-Daily Drinker
9.843800E-01
Non Drinker-vs-Weekly Drinker
3.195600E-01
Non Drinker-vs-Occasional Drinker
9.564800E-01
Non Drinker-vs-Social Drinker
4.780000E-01
Daily Drinker-vs-Weekly Drinker
3.574400E-01
Daily Drinker-vs-Occasional Drinker
9.445200E-01
Daily Drinker-vs-Social Drinker
5.203400E-01
Weekly Drinker-vs-Occasional Drinker
3.828800E-01
Weekly Drinker-vs-Social Drinker
1.572830E-01
Occasional Drinker-vs-Social Drinker
3.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.048200E-01
Normal-vs-Grade 2
7.283400E-01
Normal-vs-Grade 3
7.342800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.163100E-03
Grade 1-vs-Grade 3
1.844320E-02
Grade 1-vs-Grade 4
9.048200E-01
Grade 2-vs-Grade 3
9.110600E-01
Grade 2-vs-Grade 4
7.283400E-01
Grade 3-vs-Grade 4
7.342800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.177200E-01
Normal-vs-NonDiabetic
5.785400E-01
Diabetic-vs-NonDiabetic
7.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.460200E-01
Normal-vs-NoPancreatitis
5.860200E-01
Pancreatitis-vs-NoPancreatitis
3.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.590400E-01
Normal-vs-N1
5.465600E-01
N0-vs-N1
7.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.256800E-03
Normal-vs-TP53-NonMutant
8.092400E-01
TP53-Mutant-vs-TP53-NonMutant
9.81799999999478E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
